American Journal of Ophthalmology
Volume 146, Issue 2 , Pages 156-158 , August 2008

A Modified Technique of Ahmed Glaucoma Valve Implantation with Adjunctive Use of Antifibrotic Agents

  • Simon K. Law

      Affiliations

    • Corresponding Author InformationInquiries to Simon K. Law, 100 Stein Plaza #2-235, Jules Stein Eye Institute, Los Angeles, CA 90095

,Accepted 1 May 2008.

References 

  1. Susanna R, Nicolela MT, Takahashi WY. Mitomycin C as adjunctive therapy with glaucoma implant surgery. Ophthalmic Surg. 1994;25:458–462
  2. Lee D, Shin DH, Birt CM, et al. The effect of adjunctive mitomycin C in Molteno implant surgery. Ophthalmology. 1997;104:2126–2135
  3. Azuara-Blanco A, Moster MR, Wilson RP, Schmidt CM. Simultaneous use of mitomycin C with Baerveldt implantation. Ophthalmic Surg Lasers. 1997;28:992–997
  4. Perkins TW, Gangnon R, Ladd W, Kaufman PL, Libby CM. Molteno implant with mitomycin C: intermediate-term results. J Glaucoma. 1998;7:86–92
  5. Trible JR, Brown DB. Occlusive ligature and standardized fenestration of a Baerveldt tube with and without antimetabolites for early postoperative intraocular pressure control. Ophthalmology. 1998;105:2243–2250
  6. Kook MS, Yoon J, Kim J, Lee MS. Clinical results of Ahmed glaucoma valve implantation in refractory glaucoma with adjunctive mitomycin C. Ophthalmic Surg Lasers. 2000;31:100–106
  7. Duan X, Jiang Y, Qing G. Long-term follow-up study on Hunan aqueous drainage implantation combined with mitomycin C for refractory glaucoma. Yan Ke Xue Bao. 2003;19:81–85
  8. Irak I, Moster MR, Fontanarosa J. Intermediate-term results of Baerveldt tube shunt surgery with mitomycin C use. Ophthalmic Surg Lasers Imaging. 2004;35:189–196
  9. Cantor L, Burgoyne J, Sanders S, Bhavnani V, Hoop J, Brizendine E. The effect of mitomycin C on Molteno implant surgery: a 1-year randomized, masked, prospective study. J Glaucoma. 1998;7:240–246
  10. Kurnaz E, Kubaloglu A, Yilmaz Y, Koytak A, Ozertürk Y. The effect of adjunctive mitomycin C in Ahmed glaucoma valve implantation. Eur J Ophthalmol. 2005;15:27–31
  11. Costa VP, Azuara-Blanco A, Netland PA, Lesk MR, Arcieri ES. Efficacy and safety of adjunctive mitomycin C during Ahmed glaucoma valve implantation: a prospective randomized clinical trial. Ophthalmology. 2004;111:1071–1076
  12. Alvarado JA, Hollander DA, Juster RP, Lee LC. Ahmed valve implantation with adjunctive mitomycin C and 5-Fluorouracil: long-term outcomes. Am J Ophthalmol. 2008;146:276–284
  13. Nouri-Mahdavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the Ahmed glaucoma valve. Am J Ophthalmol. 2003;136:1001–1008
  14. Molteno AC, Dempster AG, Carne A. Molteno implants: the principles of bleb management. Aust N Z J Ophthalmol. 1999;27:350–352
  15. Molteno AC, Fucik M, Dempster AG, Bevin TH. Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmology. 2003;110:2198–2206
  16. Nuyts RM, Felten PC, Pels E, et al. Histopathologic effects of mitomycin C after trabeculectomy in human glaucomatous eyes with persistent hypotony. Am J Ophthalmol. 1994;118:225–237

 See accompanying Article on page 276.

PII: S0002-9394(08)00341-3

doi: 10.1016/j.ajo.2008.05.003

American Journal of Ophthalmology
Volume 146, Issue 2 , Pages 156-158 , August 2008

Article Tools